Sana Biotechnology SANA 深 沪
已收盘 08-08 16:00:00 美东时间
3.00
+0.030
+1.01%
华盛通- 最 高3.255
- 今 开3.05
- 成交量 848.87万股
- 最 低 2.95
- 昨 收 2.97
- 总市值 6.78亿
- 52周最高 7.30
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.26
- 委 比 -41.74%
- 总股本 2.26亿
- 历史最高 44.60
- 量 比 0.96
- 振 幅 10.27%
- 历史最低 1.26
- 每 手 1
- 风险率 1.17%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why Is Sana Biotechnology Stock Down 25% Today?
Sana Biotechnology stock fell hard on Thursday after the company announced the ...
08-07 21:28
Sana Biotechnology drops 13% on $75M stock issuance, prices at $3.35
Sana Biotechnology (NASDAQ:SANA) priced its underwritten public offering of ~20.89M shares at $3.35 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase ~1.5M s...
08-07 12:52
叙利亚达成多项国际经济合作 基建和电力大项目助经济复苏
①叙利亚民航总局与卡塔尔、土耳其和美国企业组成的联合体签署了谅解备忘录，将投资逾40亿美元改造大马士革国际机场； ②叙利亚政府与国际财团签署了一份价值70亿美元的谅解备忘录，旨在共同开发运营发电项目； ③叙利亚与土耳其成立了联合商业委员会以促进两国经济合作，并推动贸易和投资。
08-07 11:31
Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
<p>Sana Biotechnology has initiated a $75 million public offering of its common stock, with an option for underwriters to purchase an additional $11.25 million. Morgan Stanley, Goldman Sachs, BofA Securities, and TD Cowen are leading the offering. The transaction is subject to market conditions and SEC requirements. Sana aims to provide engineered cell therapies for patients across its facilities in Seattle, Cambridge, and South San Francisco.</p...
08-06 20:38
Sana Biotechnology Study Published In NEJM Shows HIP-Modified Islet Cells Function Without Immunosuppression In Type 1 Diabetes Patient
Data Demonstrate that Sana's Hypoimmune (HIP)-Modified Pancreatic Islet Cells, Transplanted with No Immunosuppression, Persist and Function Over Time in Patient with Type 1 DiabetesStudy Establishes Ability to
08-04 23:35
Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes
<p><p align="center"><em>Data Demonstrate that Sana’s Hypoimmune (HIP)-Modified Pancreatic Islet Cells, Transplanted with No Immunosuppression, Persist and Function Over Time in Patient with Type 1 Diabetes</em></p> <p align="center"><em>Study Establishes Ability to Genetically Modify and Transplant Pancreatic Islet Cells Without Immunosuppression and Overcome Both Allogeneic and Autoimmune Rejection</em></p> <p align="center"><em>Six-Month Patie...
08-04 15:35
100倍潜力股？Opendoor股价触底疯涨500%，如何在暴涨前寻找下一只“Meme股”黑马？
散户蜂拥晒单买入，投资大佬Jackson建仓看涨Opendoor至82美元！作为普通投资者，如何在暴涨前寻找下一只“Meme股”黑马？>>
07-22 14:34
美股牛股 | BTCS飙升111%！区块链业务取得重大进展；Humacyte升19%
BTCS飙升111%！区块链业务取得重大进展；Humacyte升19%，公司宣布获得美国国防物流局的Symvess ECAT批准>>
07-09 18:19
Morgan Stanley Assumes Sana Biotechnology at Overweight, Announces Price Target of $12
Morgan Stanley analyst Maxwell Skor assumes Sana Biotechnology (NASDAQ:SANA) with a Overweight rating and announces Price Target of $12.
07-04 01:21
21亿美元！艾伯维买入体内CAR-T
最近，对于跨国制药巨头（MNC）来说，细胞与基因治疗领域的投资，体内CAR-T是一种新的潮流。 2025年6月30日，艾伯维宣布将以高达21亿美元的现金收购体内...
07-01 12:31
